HIV/AIDS

Featured

tb-hiv-final

Upcoming Expert Panel: Overcoming Barriers to High-Quality TB Treatment During HIV Co-infection

While the guidelines are clear about the need to treat tuberculosis in the setting HIV infection, the reality is that many patients with HIV/TB co-infection Read More

15563555483_c309125c74_o

Large Price Premiums for Unprotected Sex Among Female Sex Workers in Kenya: A Potential…

No abstract available

14929179975_9fd8c11a7c_o

Why increasing availability of ART is not enough: a rapid, community-based study on how…

Stigma is a known barrier to HIV testing and care.

Latest

Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated…

Background: Screening for serum cryptococcal antigen (CrAg) may identify those at risk for disseminated cryptococcal disease (DCD), and preemptive fluconazole treatment may prevent progression to DCD.


Exploring the relationship between population mobility and HIV risk: Evidence from Tanzania

10.1080/17441692.2016.1178318<br/>Kevin D.


Diagnostic Accuracy of the Point-of-Care Xpert HIV-1 Viral Load Assay in a South African HIV…

No abstract available


Presence of Minority Resistant Variants After Failure of a Tenofovir, Emtricitabine, and…

No abstract available


Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008–2011

Introduction: Using National HIV surveillance system data, we estimated life expectancy and average years of life lost (AYLL) among persons diagnosed with HIV infection during 2008–2011.


Predictors of Early Breastfeeding Cessation among HIV-infected women in Botswana

Objective Infants born to HIV-infected women receiving antiretroviral treatment (ART) can breastfeed through at least 6 months with very low risk of HIV acquisition.


HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for…

Objective: To examine how the time from HIV testing to care referral and from referral to care linkage influenced time to care engagement for newly diagnosed HIV-infected adolescents.


When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in…

Objective: To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies in HIV-positive individuals on antiretroviral therapy (ART).


Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess…

Background: HIV infection and biomarkers of inflammation [measured by interleukin-6 (IL-6)], monocyte activation [soluble CD14 (sCD14)], and coagulation (D-dimer) are associated with morbidity and mortality.


Mechanisms for the Negative Effects of Internalized HIV-Related Stigma on Antiretroviral…

Background: Internalization of HIV-related stigma may inhibit a person’s ability to manage HIV disease through adherence to treatment regimens.


Investing In Challenging Operating Environments Critical To Ending HIV, TB, Malaria Epidemics

Huffington Post: Overcoming Challenges in Global Health Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “…The fight against [HIV, TB, and malaria] is more important than ever in a world increasingly affected by natural disasters, conflict and economic crises. … This new reality is why the Global Fund has…More


WHA69: Leave no one behind, World Hepatitis Alliance

Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week). Raquel’s piece is part of a series of articles Translational Global Health will run on WHA69. If you or your organisation have a particular focus at the Assembly you feel requires urgent attention, contact our Editor. We are at a turning point. This week, 194 countries will convene to decide the fate of millions of people living with viral hepatitis. At the 69th World Health Assembly in Geneva (23 – 28 May), governments will deliberate on the adoption of WHO’s first ever Global Health Sector Strategy for Viral Hepatitis (GHSS), which sets a goal of eliminating hepatitis B and C by 2030, two significant public health issues that can lead to cirrhosis, liver cancer and death.


Trends in Serosorting and the Association With HIV/STI Risk Over Time Among Men Who Have Sex…

Background: Serosorting among men who have sex with men (MSM) is common, but recent data to describe trends in serosorting are limited.


Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among…

Introduction: Improving HIV outcomes among severely immunocompromised HIV-infected persons who have increased morbidity and mortality remains an important issue in sub-Saharan Africa.


Older Posts »